Integrating high-content screening and ligand-target prediction to identify mechanism of action
- 9 December 2007
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 4 (1) , 59-68
- https://doi.org/10.1038/nchembio.2007.53
Abstract
High-content screening is transforming drug discovery by enabling simultaneous measurement of multiple features of cellular phenotype that are relevant to therapeutic and toxic activities of compounds. High-content screening studies typically generate immense datasets of image-based phenotypic information, and how best to mine relevant phenotypic data is an unsolved challenge. Here, we introduce factor analysis as a data-driven tool for defining cell phenotypes and profiling compound activities. This method allows a large data reduction while retaining relevant information, and the data-derived factors used to quantify phenotype have discernable biological meaning. We used factor analysis of cells stained with fluorescent markers of cell cycle state to profile a compound library and cluster the hits into seven phenotypic categories. We then compared phenotypic profiles, chemical similarity and predicted protein binding activities of active compounds. By integrating these different descriptors of measured and potential biological activity, we can effectively draw mechanism-of-action inferences.Keywords
This publication has 37 references indexed in Scilit:
- Small molecule screening by imagingCurrent Opinion in Chemical Biology, 2006
- CellProfiler: image analysis software for identifying and quantifying cell phenotypesGenome Biology, 2006
- Cellular imaging in drug discoveryNature Reviews Drug Discovery, 2006
- High‐Content Screening: Emerging Hardware and Software TechnologiesPublished by Elsevier ,2006
- The principle of complementarity: chemical versus biological spaceCurrent Opinion in Chemical Biology, 2005
- Small‐Molecule Screening and Profiling by Using Automated MicroscopyChemBioChem, 2005
- Advances in High Content Screening for Drug DiscoveryASSAY and Drug Development Technologies, 2003
- Aurantimycins, New Depsipeptide Antibiotics from Streptomyces aurantiacus IMET 43917 Production, Isolation, Structure Elucidation, and Biological Activity.The Journal of Antibiotics, 1995
- Antitumor activity of heptelidic acid chlorohydrin.The Journal of Antibiotics, 1994
- "General Intelligence," Objectively Determined and MeasuredThe American Journal of Psychology, 1904